
Fertility Research Library
Discover the latest medical journal articles and conference presentation topics from US Fertility-affiliated authors.
COMMENTARY: AN "IRON-CLAD" LINK BETWEEN OBESITY AND ACCELERATED DEPLETION OF THE OVARIAN RESERVE
Johnson J, Polotsky AJ. Commentary: An “iron-clad” link between obesity and accelerated depletion of the ovarian reserve. Fertil Steril. 2023 Aug 4:S0015-0282(23)00726-4. doi: 10.1016/j.fertnstert.2023.08.003. Epub ahead of print. PMID: 37544472.
Where next for improved embryo selection?
Widra EA. Where next for improved embryo selection? Fertil Steril. 2023 Aug;120(2):217. doi: 10.1016/j.fertnstert.2023.06.024. Epub 2023 Jun 26. PMID: 37380097.
REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY NURSE ONLINE ORIENTATION PROGRAM EVALUATION: A QUALITY IMPROVEMENT INITIATIVE (IN PRESS)
Vlasic J, Stevenson E, Landrum M, Gedzyk-Nieman S, Wood J, Reproductive Endocrinology and Infertility Nurse Online Orientation Program Evaluation: A Quality Improvement
Initiative, F&S Reports (2023), doi: 10.1016/j.xfre.2023.07.002.
COMBINING EARLY PREGNANCY BLEEDING WITH ULTRASOUND MEASUREMENTS TO ASSESS SPONTANEOUS ABORTION RISK AMONG INFERTILE PATIENTS
Pollie MP, Romanski PA, Bortoletto P, Spandorfer SD. Combining early pregnancy bleeding with ultrasound measurements to assess spontaneous abortion risk among infertile patients. Am J Obstet Gynecol. 2023 Jul 23:S0002-9378(23)00503-3. doi: 10.1016/j.ajog.2023.07.031. Epub ahead of print. PMID: 37487856.
SCHOLARLY ACTIVITY FOLLOWING NATIONAL INSTITUTES OF HEALTH WOMEN'S REPRODUCTIVE HEALTH RESEARCH K12 TRAINING-A COHORT STUDY
McCoy EE, Katz R, Louden DKN, Oshima E, Murtha A, Gyamfi-Bannerman C, Santoro N, Howell EA, Halvorson L, Reed SD, Goff BA. Scholarly activity following National Institutes of Health Women’s Reproductive Health Research K12 training-a cohort study. Am J Obstet Gynecol. 2023 Jul 16:S0002-9378(23)00452-0. doi: 10.1016/j.ajog.2023.06.050. Epub ahead of print. PMID: 37437707.
EFFICACY AND SAFETY OF FEZOLINETANT IN MODERATE TO SEVERE VASOMOTOR SYMPTOMS ASSOCIATED WITH MENOPAUSE: A PHASE 3 RCT
Johnson KA, Martin N, Nappi RE, Neal-Perry G, Shapiro M, Stute P, Thurston RC, Wolfman W, English M, Franklin C, Lee M, Santoro N. Efficacy and Safety of Fezolinetant in Moderate to Severe Vasomotor Symptoms Associated With Menopause: A Phase 3 RCT. J Clin Endocrinol Metab. 2023 Jul 14;108(8):1981-1997. doi: 10.1210/clinem/dgad058. PMID: 36734148; PMCID: PMC10348473.
Validation of prognosis-based in vitro fertilization grant selection criteria
Bakkensen JB, Heisler E, Bolten K, Yilmaz B, Smiley J, Hirshfeld-Cytron JE, Feinberg EC. Validation of prognosis-based in vitro fertilization grant selection criteria. F S Rep. 2023 Jul 5;4(3):286-291. doi: 10.1016/j.xfre.2023.06.006. PMID: 37719099; PMCID: PMC10504529.
MEDICAL STUDENT DUTY HOURS AND SHELF PERFORMANCE: IS THERE A CORRELATION?
Harris BS, Harris HM, Baldwin MA, Dotters-Katz SK. Medical Student Duty Hours and Shelf Performance: Is There a Correlation? Am J Perinatol. 2023 Jul 4. doi: 10.1055/a-2099-8611. Epub ahead of print. PMID: 37230478.
The Impact of the FertiStrong Mobile Application on Anxiety and Depression in Men: A Randomised Control Pilot Study
Domar AD, Jasulaitis L, Matevossian K, Jasulaitis S, Grill EA, Uhler ML. The Impact of the FertiStrong Mobile Application on Anxiety and Depression in Men: A Randomised Control Pilot Study. J Hum Reprod Sci. 2023 Jul-Sep;16(3):195-203. doi: 10.4103/jhrs.jhrs_75_23. Epub 2023 Sep 29. PMID: 38045496; PMCID: PMC10688279.
Reply of the Authors: Recurrent implantation failure: reality or a statistical mirage?
Pirtea P, Cedars MI, Devine K, Ata B, Franasiak J, Racowsky C, Toner J, Scott RT, de Ziegler D, Barnhart KT. Reply of the Authors: Recurrent implantation failure: reality or a statistical mirage? Fertil Steril. 2023 Jul;120(1):211. doi: 10.1016/j.fertnstert.2023.04.012. Epub 2023 Apr 14. PMID: 37061158.
Recurrent implantation failure: reality or a statistical mirage?: Consensus statement from the July 1, 2022 Lugano Workshop on recurrent implantation failure
Pirtea P, Cedars MI, Devine K, Ata B, Franasiak J, Racowsky C, Toner J, Scott RT, de Ziegler D, Barnhart KT. Recurrent implantation failure: reality or a statistical mirage?: Consensus statement from the July 1, 2022 Lugano Workshop on recurrent implantation failure. Fertil Steril. 2023 Jul;120(1):45-59. doi: 10.1016/j.fertnstert.2023.02.014. Epub 2023 Feb 22. PMID: 36822566.
Recurrent implantation failure: Are we throwing Hail Mary on Third Down?
Hariton E, Andrusier M, Fine E. Recurrent implantation failure: Are we throwing Hail Mary on Third Down? Fertil Steril. 2023 Jul;120(1):60. doi: 10.1016/j.fertnstert.2023.04.037. Epub 2023 May 3. PMID: 37142049.
Applications of artificial intelligence in ovarian stimulation: a tool for improving efficiency and outcomes
Hariton E, Pavlovic Z, Fanton M, Jiang VS. Applications of artificial intelligence in ovarian stimulation: a tool for improving efficiency and outcomes. Fertil Steril. 2023 Jul;120(1):8-16. doi: 10.1016/j.fertnstert.2023.05.148. Epub 2023 May 19. PMID: 37211063.
TYPE AND AGE OF MENOPAUSE: POTENTIAL IMPLICATIONS FOR FEMALE SEXUAL HEALTH
Liss J, Pettigrew J, Santoro N. Type and age of menopause: potential implications for female sexual health. J Sex Med. 2023 Jun 28;20(7):921-924. doi: 10.1093/jsxmed/qdad021. PMID: 37386930.
WHERE NEXT FOR IMPROVED EMBRYO SELECTION?
Widra EA. Where next for improved embryo selection? Fertil Steril. 2023 Aug;120(2):217. doi: 10.1016/j.fertnstert.2023.06.024. Epub 2023 Jun 26. PMID: 37380097.
NEUROKININ RECEPTOR ANTAGONISTS AS POTENTIAL NON-HORMONAL TREATMENTS FOR VASOMOTOR SYMPTOMS OF MENOPAUSE
Conklin M, Santoro N. Neurokinin receptor antagonists as potential non-hormonal treatments for vasomotor symptoms of menopause. Ther Adv Reprod Health. 2023 Jun 22;17:26334941231177611. doi: 10.1177/26334941231177611. PMID: 37388717; PMCID: PMC10302519.
HUMAN AND MOUSE EMBRYONIC GENOME ACTIVATION INITIATES AT THE ONE-CELL STAGE
Asami, M., Lam, B. Y. H., VerMilyea, M. D., Klein, C. A., Yeo, G. S. H., & Perry, A. (2023). HUMAN AND MOUSE EMBRYONIC GENOME ACTIVATION INITIATES AT THE ONE-CELL STAGE. Poster session presented at ISSCR 2023 Annual Meeting, Boston, USA United States.
PREIMPLANTATION GENETIC TESTING FOR SICKLE CELL DISEASE – A COST EFFECTIVENESS ANALYSIS (IN PRESS)
Joshua Combs, Maura Dougherty, Meghan Yamasaki, Alan DeCherney, Kate Devine, Micah Hill, Erin Rothwell, Jeanne O’Brien, Richard Nelson. F&S Reports. doi:https://doi.org/10.1016/j.xfre.2023.06.001
FETAL GROWTH VELOCITY ACCORDING TO THE MODE OF ASSISTED CONCEPTION
Caradeux Bull J, Avila F, Vargas F, Fernandez B, Winkler C, Mondion M, Rojas I, Figueras F. Fetal growth velocity according to the mode of assisted conception. Fetal Diagn Ther. 2023 Jun 12. doi: 10.1159/000531451. Epub ahead of print. PMID: 37307807.
EFFECTS OF PULSATILE INTRAVENOUS FOLLICLE-STIMULATING HORMONE TREATMENT ON OVARIAN FUNCTION IN WOMEN WITH OBESITY
Luu TH, Kuhn K, Bradford AP, Wempe MF, Wittenburg L, Johnson RL, Carlson NE, Kumar TR, Polotsky AJ. Effects of pulsatile intravenous follicle-stimulating hormone treatment on ovarian function in women with obesity. Fertil Steril. 2023 Jun 3:S0015-0282(23)00588-5. doi: 10.1016/j.fertnstert.2023.05.170. Epub ahead of print. PMID: 37276947.